Shanghai Securities News China Securities Network News On the evening of August 28, Xiamen International Trade announced its 2025 semi-annual report. In the first half of the year, it achieved operating income of 151.658 billion yuan; net profit attributable to shareholders of the listed company was 523 million yuan. The company continues to promote the upgrade of the "three-chain integration" business model, adheres to business transformation and model innovation, increases investment in real industries and international layout, and creates differentiated core competitiveness.

The report shows that Xiamen International Trade’s supply chain management business achieved operating income of 151.09 billion yuan, of which overseas business operating income was 29.545 billion yuan; the total import and export volume was 6.579 billion US dollars; the “Belt and Road” trade scale was nearly 40 billion yuan; the trade scale with RCEP countries exceeded 35 billion yuan. Facing the complex and ever-changing market environment, the company adheres to integrity and innovation, optimizes business structure, focuses on high-quality business, and steadily improves the operating quality and profitability of major products such as iron ore, copper, and liquid chemicals. In order to support the spot operation of the supply chain management business, the company rationally uses financial derivatives such as futures contracts and foreign exchange contracts to hedge the risk of commodity price fluctuations and exchange rate fluctuations. In the first half of the year, it generated non-recurring profits and losses of 1.015 billion yuan. This part of the profits and losses is closely related to the company's main business operating profits and losses, effectively reducing the company's operating risks.

The company has strengthened its industrial development and expanded upstream resources in multiple categories through long-term agreements and industrial cooperation. It has participated in the cooperative operation of a 400,000-ton differentiated polyester filament factory project to promote the textile industry chain and deepened industrial operations. It has added new export sales orders for oil and chemical ships and expanded its cooperative business in ship manufacturing.

The company continues to improve its international layout. It has newly established an Australian platform company and a Japanese office of Guomao New Energy Co., Ltd., accelerated overseas permanent and local recruitment to expand overseas teams; expanded overseas upstream resources such as sulfur, African copper, and aluminum, and newly signed 23 overseas warehouses in Uzbekistan, Vietnam, Zimbabwe and other countries to improve overseas warehousing nodes and logistics service capabilities. The Uzbekistan cotton yarn purchased by the company took the first Tashkent-Fuzhou Central Asia train to go directly to Fujian to supply local textile enterprises, building an industrial chain of "Central Asia cotton yarn-Fujian weaving-global sales" and opening up an efficient logistics channel for Central Asia's high-quality bulk resources to "come in" and for my country's textile industry to "go out".

The company iterated on the "Guomao Cloud Chain" digital system functions and used data to drive business development. The cumulative orders exceeded 70,000 and the transaction value exceeded 30 billion yuan. "Guomao Cloud Chain" integrates the R1 large model to provide users with services such as self-service ordering, market information and customer service consultation, effectively improving users' interactive experience and business processing efficiency. The newly launched international platform system optimizes system functions such as fund management system and commodity exposure management, and continues to strengthen the middle and back-end management systems to improve management efficiency.

The company's health technology business achieved operating income of 544 million yuan. Its subsidiary Pilot Medical continued to expand its sales network, strengthen R&D innovation and brand building, and achieved operating income of 262 million yuan, of which overseas revenue accounted for approximately 55%, and net profit attributable to the parent company of 55.66 million yuan. The medical consumables SPD and delivery and distribution business have added multiple hospital projects in many places, further expanding the coverage area of ​​the medical device supply chain business. (Lu Xiaohui)